Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Sodium zirconium cyclosilicate for treating hyperkalaemia
Drug guidance

Sodium zirconium cyclosilicate for treating hyperkalaemia

Condition

Kidney

19 December 2022

Published on 19 Dec 2022
Last Updated on 19 Dec 2022

Guidance Recommendations

The Ministry of Health's Drug Advisory Committee has not recommended listing sodium zirconium cyclosilicate on the MOH List of Subsidised Drugs for treating hyperkalaemia due to the uncertain extent of clinical benefit and uncertain cost effectiveness compared with current standard of care.

Sodium zirconium cyclosilicate for treating hyperkalaemia (19 December 2022) [PDF, 133 KB]

PES Sodium zirconium cyclosilicate for treating hyperkalaemia (19 December 2022) [PDF, 115 KB]

Back to top